Concepedia

Shawn F. Johnson

SF

Statistics

Publications

10

Citations

2.1K

H-Index

10

Active since

2012

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Fox Chase Cancer Center

University of Washington

Shawn F. Johnson is an author at Harvard University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2012–2022

10

Publications

10

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera et al. · Nature · 2017 · 551 citations · Full text

, , +12

Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer

Jian Hu, Soyoon Hwang, Marc Liesa et al. · Cell · 2012 · 290 citations · Full text

, , +9

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

Shawn F. Johnson, Cristina Cruz, Ann Katrin Greifenberg et al. · Cell Reports · 2016 · 286 citations · Full text

, , +16

The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin

Yifan Wang, Andrea J. Bernhardy, Cristina Cruz et al. · Cancer Research · 2016 · 271 citations · Full text

, , +16

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance

Neil Johnson, Shawn F. Johnson, Wei Yao et al. · Proceedings of the National Academy of Sciences · 2013 · 265 citations · Full text

, , +15

1–5 of 10